Fritz Kunz new Numab chair
This article was originally published in Scrip
Executive Summary
Swiss biotech company Numab has appointed Dr Fritz Kunz chair of the board. Dr Kunz served as CEO of Institute Straumann from 1994-1998, and was chair of Speedel from 2000 until 2008 when it was acquired by Novartis. Currently he is also chair of Kuros and a board member at Sentec.